THE BODY MASS INDEX INFLUENCES THE ACHIEVEMENT RATIO OF TARGET BLOOD PRESSURE BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN JAPANESE TYPE 2 DIABETES PATIENTS WITH CKD

被引:0
|
作者
Kobayashi, Kazuo [1 ]
Tamura, Kouichi [2 ]
Toyoda, Masao [3 ]
Sakai, Hiroyuki [1 ]
Furuki, Takayuki [1 ]
Hatori, Nobuo [1 ]
Sato, Kazuyoshi [1 ]
Miyakawa, Masaaki [1 ]
Kanamori, Akira [1 ]
机构
[1] Kanagawa Physicians Assoc, Comm Hypertens & Kidney Dis, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Dept Internal Med, Isehara, Kanagawa, Japan
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:E211 / E211
页数:1
相关论文
共 50 条
  • [21] Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus
    Kambara, Takahiro
    Shibata, Rei
    Osanai, Hiroyuki
    Nakashima, Yoshihito
    Asano, Hiroshi
    Sakai, Kazuyoshi
    Murohara, Toyoaki
    Ajioka, Masayoshi
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2018, 18 (01) : 108 - 114
  • [22] Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes
    Trujillo, Jennifer M.
    Nuffer, Wesley A.
    PHARMACOTHERAPY, 2017, 37 (04): : 481 - 491
  • [23] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
    Abrahami, Devin
    Douros, Antonios
    Yin, Hui
    Yu, Oriana H. Y.
    Azoulay, Laurent
    DIABETES CARE, 2019, 42 (09) : E150 - E152
  • [25] Sodium-Glucose Cotransporter 2 Inhibitors Significantly Lower the Cardiac Electrophysiological Balance Index in Type 2 Diabetes Patients
    Ozdemir, Emrah
    Ziyrek, Murat
    Donmez, Esra
    Ozcan, Sevgi
    Ince, Orhan
    Gevher, Ceyla Zeynep Colakoglu
    Ozdemir, Bahar
    Okuyan, Ertugrul
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2025, 53 (02): : 113 - 119
  • [26] Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study
    Mori, Yuichiro
    Komura, Toshiaki
    Adomi, Motohiko
    Yagi, Ryuichiro
    Fukuma, Shingo
    Kondo, Naoki
    Yanagita, Motoko
    Duru, O. Kenrik
    Tuttle, Katherine R.
    Inoue, Kosuke
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [27] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
  • [28] A systematic review of sodium-glucose cotransporter 2 inhibitors and renal profiles among Japanese patients with type 2 diabetes mellitus
    Mukai, Junichi
    Okamura, Nakaba
    Saito, Yuki
    Kubota, Rie
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [29] A systematic review of sodium-glucose cotransporter 2 inhibitors and renal profiles among Japanese patients with type 2 diabetes mellitus
    Junichi Mukai
    Nakaba Okamura
    Yuki Saito
    Rie Kubota
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [30] Considerations and possibilities for sodium-glucose cotransporter 2 inhibitors in pediatric CKD
    Kula, Alexander J.
    PEDIATRIC NEPHROLOGY, 2022, 37 (10) : 2267 - 2276